by admin | Sep 6, 2022 | press releases
Breaking News in #maculardegeneration! First time in USA! Commencement of a Phase 1/2a clinical safety trial using #IPSC stem cells to treat for advanced dry age-related macular degeneration. NIH and #JohnHopkins surgical team implanted a patch of tissue made from...
by admin | Sep 2, 2022 | news articles
By Vivienne Raper, PhD – Genengnews.com The future of cell therapies should be in off-the-shelf products using multiplex gene editing during the manufacturing process. That’s according to Rachel Haurwitz, PhD, CEO of Caribou Biosciences. Haurwitz, whose...